Kura Oncology Inc (KURA) Company Profile & Statistics

Kura Oncology Inc
KURA
(Nasdaq - US)
Closed
17.82
+0.94 (+5.57%)
in:usd•As of: Nov 04, 2024 15:59 UTC -5
Open
16.70
High
17.86
Low
16.61

About Kura Oncology Inc

CEO

Troy E. Wilson

Headquarters

12730 high bluff drive, suite 400

san diego, ca 92130, united states

Auditor

Ernst & Young LLP

Employees

142

Share Holders

106

Website

www.kuraoncology.com

Industry

biotechnology

Sector

health technology

Company Overview

Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL, ERK inhibitor program and Menin MLL inhibitor program. Kura Oncology, Inc. is headquartered in La Jolla, California.

Kura Oncology Inc Statistics

Valuation Measures

Market Capitalization ²	1.37B
Enterprise Value	1.33B
Enterprise Value/EBITDA (ttm)	-6.28
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.76
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-40.43%
Return on Invested Capital (ttm)	-39.65%
Return on Assets (ttm)	-36.50%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-211.67M
Net Income Avi to Common (ttm)	-181.75M
Diluted EPS (ttm)	-2.23

Share Statistics

Beta (5Y Monthly)	0.86
52-Week Change	98.22%
S&P500 52-Week Change	30.85%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	76.63M
Dividend Yield	0.00%
Float ⁴	72.42M
% Held by Insiders	5.50%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	491.52M
Total Cash Per Share (mrq)	6.41
Total Debt (mrq)	9.42M
Total Debt/Equity (mrq)	2.02%
Current Ratio (mrq)	14.94%
Quick Ratio (mrq)	14.94%
Book Value Per Share (mrq)	6.10

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.05
Free Cash Flow (ytd)	-91.47M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Kura Oncology Inc

Trade With A Regulated Broker